Personal information

Activities

Collapse all

Works (2)

Efficacy and Safety of the Natural Killer T Cell–Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial

JMIR Research Protocols
2024-01-15 | Journal article
DOI: 10.2196/46709
Contributors: Tomoko Okamoto; Takami Ishizuka; Reiko Shimizu; Yasuko Asahina; Harumasa Nakamura; Yuko Shimizu; Yoichiro Nishida; Takanori Yokota; Youwei Lin; Wakiro Sato et al.
Source: check_circle
Crossref

Efficacy and Safety of the Natural Killer T Cell–Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial (Preprint)

2023-02-23 | Preprint
DOI: 10.2196/preprints.46709
Contributors: Tomoko Okamoto; Takami Ishizuka; Reiko Shimizu; Yasuko Asahina; Harumasa Nakamura; Yuko Shimizu; Yoichiro Nishida; Takanori Yokota; Youwei Lin; Wakiro Sato et al.
Source: check_circle
Crossref
How many people are using ORCID?